3,4-Dihydroxyphenylacetaldehyde: A Potential Target for Neuroprotective Therapy in Parkinson's Disease

Publisher： Bentham Science Publishers

E-ISSN： 2212-5299|2|2|143-148

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.2, Iss.2, 2003-04, pp. : 143-148

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Curcumin: A Potential Neuroprotective Agent in Parkinson's Disease

By  

Current Pharmaceutical Design, Vol. 18, Iss. 1, 2012-01 ,pp. : 91-99

Bentham Science Publishers

Access to resources Recommend Favorite

Nociceptinergic System as Potential Target in Parkinson’s Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 10, 2013-01 ,pp. : 1389-1397

Bentham Science Publishers

Access to resources Recommend Favorite

Humanin: a potential peptide for neuroprotective therapy against Alzheimer's disease

By Niikura Takako  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 9, 2007-09 ,pp. : 1273-1282

Informa Healthcare

Access to resources Recommend Favorite

Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson’s Disease

By  

Current Medicinal Chemistry, Vol. 23, Iss. 7, 2016-02 ,pp. : 686-700

Bentham Science Publishers

Access to resources Recommend Favorite

Monoamine Oxidase Inhibitors Extracted from Tobacco Smoke as Neuroprotective Factors for Potential Treatment of Parkinson’s Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 6, 2015-01 ,pp. : 777-785

Bentham Science Publishers

Access to resources Recommend Favorite